We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBP
876
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$16K ﹤0.01%
+360
New +$14.2K
MNKD icon
877
MannKind Corp
MNKD
$1.32B
$16K ﹤0.01%
5,335
+3,381
+173% +$8.87K
REG icon
878
Regency Centers
REG
$14.1B
$16K ﹤0.01%
355
+83
+31% +$3.57K
RGA icon
879
Reinsurance Group of America
RGA
$16.1B
$16K ﹤0.01%
142
+40
+39% +$4.47K
VNDA icon
880
Vanda Pharmaceuticals
VNDA
$302M
$16K ﹤0.01%
1,255
+789
+169% +$9.5K
ODT
881
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$16K ﹤0.01%
+885
New +$13.7K
KDMN
882
DELISTED
Kadmon Holdings, Inc.
KDMN
$16K ﹤0.01%
+3,935
New +$15.5K
COLL icon
883
Collegium Pharmaceutical
COLL
$956M
$15K ﹤0.01%
795
+499
+169% +$9.74K
LKFT
884
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$15K ﹤0.01%
155
+93
+150% +$11.4K
LAD icon
885
Lithia Motors
LAD
$8.26B
$15K ﹤0.01%
53
+19
+56% +$5.2K
MGTX icon
886
MeiraGTx Holdings
MGTX
$1.21B
$15K ﹤0.01%
1,010
+692
+218% +$9.78K
PSTX
887
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$15K ﹤0.01%
+1,420
New +$15K
GTHX
888
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$15K ﹤0.01%
875
+551
+170% +$8.23K
KDNY
889
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$15K ﹤0.01%
+965
New +$14.6K
AKUS
890
DELISTED
Akouos Inc
AKUS
$15K ﹤0.01%
+790
New +$15.4K
RIGL icon
891
Rigel Pharmaceuticals
RIGL
$750M
$14K ﹤0.01%
403
+259
+180% +$7.5K
VNO icon
892
Vornado Realty Trust
VNO
$7.38B
$14K ﹤0.01%
379
+107
+39% +$3.91K
ISEE
893
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14K ﹤0.01%
+2,055
New +$13.1K
RUBY
894
DELISTED
Rubius Therapeutics, Inc
RUBY
$14K ﹤0.01%
1,855
+1,165
+169% +$6.92K
AERI
895
DELISTED
Aerie Pharmaceuticals
AERI
$14K ﹤0.01%
1,075
+679
+171% +$8.21K
ANAB icon
896
AnaptysBio
ANAB
$1.68B
$13K ﹤0.01%
630
+398
+172% +$9.66K
ARDX icon
897
Ardelyx
ARDX
$997M
$13K ﹤0.01%
2,070
+1,310
+172% +$7.78K
FRT icon
898
Federal Realty Investment Trust
FRT
$10.3B
$13K ﹤0.01%
157
+55
+54% +$4.58K
KNSA icon
899
Kiniksa Pharmaceuticals
KNSA
$5.93B
$13K ﹤0.01%
+740
New +$13K
LEGN icon
900
Legend Biotech
LEGN
$4.01B
$13K ﹤0.01%
+490
New +$14.1K
34 35
36
37 38

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.